Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

110 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Short-, mid- and long-term efficacy of dupilumab in moderate-to-severe atopic dermatitis: a real-world multicentre Italian study of 2576 patients.
Ferrucci S, Tavecchio S, Maronese CA, Balato A, Di Brizzi EV, Ortoncelli M, Ribero S, Girolomoni G, Maurelli M, Fortina AB, Caroppo F, Naldi L, Pezzolo E, Nettis E, Pugliese F, Stingeni L, Hansel K, Rubegni G, Calabrese L, Russo F, Gola M, Magnaterra E, Rongioletti F, Mercuri SR, Paolino G, Savoia P, Veronese F, Foti C, Ambrogio F, Scalvenzi M, Napolitano M, Patruno C, Dastoli S, Corazza M, Borghi A, Calzavara-Pinton PG, Rossi M, Offidani A, Radi G, Bonzano L, Ferreli C, Piras V, Satta R, Sucato F, Malagoli P, Gaiani F, Micali G, Musumeci ML, Fargnoli MC, Esposito M, Grieco T, Chello C, Casazza G, Marzano AV. Ferrucci S, et al. Among authors: malagoli p. Clin Exp Dermatol. 2024 Nov 22;49(12):1561-1572. doi: 10.1093/ced/llae208. Clin Exp Dermatol. 2024. PMID: 38860563
Secukinumab drug survival in patients with psoriasis: A multicenter, real-world, retrospective study.
Torres T, Balato A, Conrad C, Conti A, Dapavo P, Ferreira P, Gaiani F, Leite L, Malagoli P, Mendes-Bastos P, Megna M, Messina F, Nidegger A, Odorici G, Piaserico S, Prignano F, Ribero S, Ricceri F, Tonini A, Valério J, Chiricozzi A. Torres T, et al. Among authors: malagoli p. J Am Acad Dermatol. 2019 Jul;81(1):273-275. doi: 10.1016/j.jaad.2019.02.031. Epub 2019 Feb 18. J Am Acad Dermatol. 2019. PMID: 30790602 No abstract available.
Secukinumab shows high efficacy irrespective of HLA-Cw6 status in patients with moderate-to-severe plaque-type psoriasis: results from extension phase of the SUPREME study.
Papini M, Cusano F, Romanelli M, Burlando M, Stinco G, Girolomoni G, Peris K, Potenza C, Offidani A, Bartezaghi M, Aloisi E, Costanzo A; SUPREME study group. Papini M, et al. Br J Dermatol. 2019 Aug;181(2):413-414. doi: 10.1111/bjd.18013. Epub 2019 May 29. Br J Dermatol. 2019. PMID: 31001812 Clinical Trial. No abstract available.
110 results